MTOR and non-small cell lung carcinoma: Knockdown of miR-126, miR-203, and miR-34a has been demonstrated to regulate drug resistance via PI3K/AKT signaling.23–25 Furthermore, miRNAs can regulate upstream factors of the PI3K/AKT/mTOR pathways in NSCLC.